66 related articles for article (PubMed ID: 8587428)
1. The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury.
Barone FC; White RF; Elliott JD; Feuerstein GZ; Ohlstein EH
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S404-7. PubMed ID: 8587428
[TBL] [Abstract][Full Text] [Related]
2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
3. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
Zhang Y; Belayev L; Zhao W; Irving EA; Busto R; Ginsberg MD
Brain Res; 2005 May; 1045(1-2):150-6. PubMed ID: 15910773
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
[TBL] [Abstract][Full Text] [Related]
5. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.
Schäbitz WR; Schwab S; Spranger M; Hacke W
J Cereb Blood Flow Metab; 1997 May; 17(5):500-6. PubMed ID: 9183287
[TBL] [Abstract][Full Text] [Related]
6. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats.
Briyal S; Gulati K; Gulati A
Brain Res; 2012 Jan; 1427():23-34. PubMed ID: 22055454
[TBL] [Abstract][Full Text] [Related]
10. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide scavenger carboxy-PTIO reduces infarct volume following permanent focal ischemia.
Fang SY; Tseng CC; Yang YL; Lee EJ; Chen HY; Bhardwaj A; Chen TY
Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):141-6. PubMed ID: 17037001
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia.
Patel TR; Galbraith S; Graham DI; Hallak H; Doherty AM; McCulloch J
J Cereb Blood Flow Metab; 1996 Sep; 16(5):950-8. PubMed ID: 8784239
[TBL] [Abstract][Full Text] [Related]
13. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats.
Lämmer A; Günther A; Beck A; Krügel U; Kittner H; Schneider D; Illes P; Franke H
Eur J Neurosci; 2006 May; 23(10):2824-8. PubMed ID: 16817887
[TBL] [Abstract][Full Text] [Related]
15. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
Sayeed I; Guo Q; Hoffman SW; Stein DG
Ann Emerg Med; 2006 Apr; 47(4):381-9. PubMed ID: 16546625
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats.
Kläsner B; Lumenta DB; Pruneau D; Zausinger S; Plesnila N
Neurochem Int; 2006 Oct; 49(5):442-7. PubMed ID: 16624448
[TBL] [Abstract][Full Text] [Related]
17. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia.
Chiba Y; Sasayama T; Miyake S; Koyama J; Kondoh T; Hosoda K; Kohmura E
Kobe J Med Sci; 2008 Jul; 54(2):E136-46. PubMed ID: 18772615
[TBL] [Abstract][Full Text] [Related]
19. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats.
Nagayama M; Zhang F; Iadecola C
J Cereb Blood Flow Metab; 1998 Oct; 18(10):1107-13. PubMed ID: 9778187
[TBL] [Abstract][Full Text] [Related]
20. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia.
Günther A; Küppers-Tiedt L; Schneider PM; Kunert I; Berrouschot J; Schneider D; Rossner S
Eur J Neurosci; 2005 Jun; 21(11):3189-94. PubMed ID: 15978027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
